STOK
Stoke Therapeutics Inc.
Company Overview
| Mkt Cap | $1.73B | Price | $30.04 |
| Volume | 1.34M | Change | -5.24% |
| P/E Ratio | -19.5 | Open | $31.58 |
| Revenue | $36.6M | Prev Close | $31.70 |
| Net Income | $-89.0M | 52W Range | $5.35 - $38.69 |
| Div Yield | N/A | Target | $28.22 |
| Overall | 63 | Value | 60 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyStoke Therapeutics Inc. (STOK) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $30.04 with a market capitalization of $1.73 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows STOK with a volume of 1.34 million shares. The stock opened down 0.38% from yesterday's close of $31.70. Current analyst estimates project earnings of $0.28 per share for this year, with next year targeting $-2.86.
STOK demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for STOK include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -6.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 05:03 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STOK | $30.04 | -5.2% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |